Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Lymphovenous Bypass Procedure Following Axillary Lymphadenectomy
NCT03941756Recruiting
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Aug 2018
- Primary completion
- Jan 2027
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by University of Texas MD Anderson Cancer Center. Primary endpoints: Volumetric diagnosis of lymphedema at 18 months and Incidence of lymphedema at 18 months. Started Aug 2018; status: recruiting.
Beyond the preview
Go deeper on NCT03941756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03941756.